Dr. Sidharth Mehan
My Social Links

Dr. Sidharth Mehan

Professor
Indo Soviet Friendship College of Pharmacy, India


Share this Profile

Biography

Dr. Sidharth Mehan, Ph.d., M.Pharm (Pharmacology) is working as Associate Professor in Department of Pharmacology at ISF College of Pharmacy, Moga, Punjab, India, one of the best well renowned and prestigious pharma education and research institute in India. Dr. Mehan has more than 12 years of academics, research and administrative experience to his credit. He has published more than 70 research and review articles in prestigious international journals.

His areas of research include neuroscience, pharmacology, molecular neurobiology, drug discovery. The thought provoking academic talks delivered by Dr. Mehan as an invited speaker during national and international conferences reflect his excellent oratory and communication skills.

He has so far guided 40 M.Pharm research projects and 02 doctoral theses. Furthermore, he is associated with animal welfare and social activities for last 15 years. Dr. Mehan has bagged several research paper awards in national and international conferences.

Dr. Mehan is a member/in-charge of various national/international pharmaceutical and clinical therapeutic committees. He is editor/reviewer of various national and international journals and magazines. Dr. mehan is author of two international books in Springer Nature.

Dr. Mehan to obtain a challenging and responsible position in the field of pharmacology and molecular biotechnology Research that fosters creativity and innovation through confidence, flexibility, and freedom to work for achieving the organizational goals coupled with enhancing my knowledge and professional skills.

Area of Interest:

Pharmacology and Toxicology
100%
Neuropharmacology
62%
Phytochemicals
90%
Herbal Formulation
75%
Pharmacology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
82
Abstracts
0

Selected Publications

  1. Kaur, G., U. Kukkar and S. Mehan, 2016. Ameliorative strategies of natural adenyl cyclase activator to restore the mitochondrial dysfunction against 6-ohda induced Parkinson's type neurodegenerative disorders. IJPPR, 6: 21-30.
  2. Parveen, S., S. Mehan, G. Kaur and U. Kukkar, 2015. Therapeutic potential of nature molecule forskolin mediated cyclic AMP/CREB activation for the amelioration of neurodegenerative disorder like huntington's. Int. J. Rec. Adv. Pharm. Res., 5: 296-301.
  3. Kaur, R., S. Parveen, S. Mehan, D. Khanna and S. Kalra, 2015. Neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer’s type memory and cognitive dysfunctions: Possible behavioural and biochemical evidences. Int. J. Preven. Med. Res, 1: 45-64.
    Direct Link  |  
  4. Kaur, R., S. Mehan, S. Parveen, D. Khanna and S. Kalra, 2015. Precautionary ellagic acid treatment ameliorates chronically administered scopolamine induced alzheimer's type memory and cognitive dysfunctions in rats. Pharmacologia, 6: 192-212.
  5. Kaur, R., S. Mehan, D. Khanna and S. Kalra, 2015. Polyphenol ellagic acid-targeting to brain: A hidden treasure. Int. J. Neurol. Res., 1: 141-152.
    Direct Link  |  
  6. Kaur, R., S. Mehan, D. Khanna and S. Kalra, 2015. Ameliorative treatment with ellagic acid in scopolamine induced alzheimer's type memory and cognitive dysfunctions in rats. Austin J. Clin. Neurol., 2: 1-11.
  7. Kaur, G., S. Mehan and D. Khanna, 2015. Pharmacotherapeutic strategies associated with blood brain barrier to prevent brain tumors. Int. J. Recent Adv. Pharm. Edu Res., 5: 51-86.
  8. Bala, R., D. Khanna, S. Mehan and S. Kalra, 2015. Experimental evidence for the potential of Lycopene in the management of scopolamine induced amnesia. RSC Adv., 5: 72881-72892.
    CrossRef  |  Direct Link  |  
  9. Thakur, T., S. Mehan, R. Kaur and S. Kalra, 2014. Huntington's disease: A hard nut to break. Int. J. Recent Adv. Pharm. Res., 4: 38-58.
  10. Paliwal, Y.K., S. Mehan, K.R.V. Bijjem and P.L. Sharma, 2014. Renoprotective effect of ace Inhibitor -lisinopril and heme Oxygenase-1 Inducer-hemin combination against streptozotocin induced advanced diabetic nephropathy in rats. Pharmacologia, 5: 60-75.
    CrossRef  |  Direct Link  |  
  11. Gagandeep, B.S., Y. Sharma, R. Ahlawat, S. Rani and S. Mehan, 2014. Evaluate adaptogenic activity of fruits of Lagenaria siceraria by animal models. Int. J. Recent. Adv. Pharm. Res., 4: 85-101.
    Direct Link  |  
  12. Sharma, R., S. Mehan, S. Kalra and D. Khanna, 2013. Tephrosia purpurea-A magical herb with blessings in human biological system. Int. J. Recent. Adv. Pharm. Res., 3: 12-22.
    Direct Link  |  
  13. Paliwal, Y.K., S. Mehan and P.L. Sharma, 2013. Heme oxygenase-1: A magic stick for diabetes and renal disorders. Int. J. Recent Adv. Pharm. Res., 4: 9-22.
    Direct Link  |  
  14. Heer, H. and S. Mehan, 2013. Cellular signals like MAPK/NF-κB/m-TOR mediated drug resistance: A promising concept in cancer research. Pharmacologia, 4: 414-427.
  15. Beniwal, L., D. Khanna and S. Mehan, 2013. Spices, Fruits, Nuts and vitamins: Preventive interventions for myocardial infarction. Pharmacologia, 4: 553-570.
  16. Bansal, N., S. Mehan, S. Kalra and D. Khanna, 2013. Boswellia serrata-frankincense (A Jesus Gifted Herb): An updated pharmacological profile. Pharmacologia, 4: 457-463.
  17. Vyas, T., S. Mehan, V. Sehgal, V. Dave and A. Prajapat et al., 2011. Alzheimer's-A neurodegenerative disease: Start to end. Int. J. Pharm. Prof. Res., 2: 422-434.
  18. Tiwari, M., S. Mehan, M.P. Singh, H. Meena, K. Jangid and A. Deora, 2011. Neuroinflammatory mechanisms of cytokines in multiple sclerosis. Int. J. Pharm. Prof. Res., 2: 359-372.
  19. Sharma, G., S. Kumar, N. Sharma and S. Mehan, 2011. An updated review on multiple sclerosis. Asian J. Biopharm. Pharm. Res., 3: 415-428.
  20. Prajapat, A., V. Dave, R. Moyra, S. Mehan, G. Lal and P. Joshi, 2011. A review on effectiveness of herbal drugs in AIDS. Int. J. Biopharma Toxicol. Res., 1: 115-136.
  21. Mehan, S., R. Arora, V. Sehgal, G. Sharma, S. Singh and S. Kawal, 2011. Effect of Salvia officinalis L. (Sage) leaves in intracerebroventricular streptozotocin (ICV-STZ) induced Alzheimer's type dementia. Int. J. Bio. Tox. Res., 1: 90-107.
  22. Mehan, S., R. Arora, D. Sharma, H. Meena, G. Sharma and T. Vyas, 2011. Dementia: A complete literature review on various mechanisms involves in pathogenesis and an intracerebroventricular streptozotocin induced Alzheimer's disease. Int. J. Pharm. Prof. Res., 2: 406-421.
  23. Mehan, S., H. Meena, D. Sharma and R. Sankhla, 2011. JNK: A stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J. Mol. Neurosci., 43: 376-390.
    CrossRef  |  PubMed  |  Direct Link  |  
  24. Mehan, S., G. Sharma, S. Kumar, M. George and L. Joseph et al., 2011. Evaluation of the antipyretic and analgesic activity of aqueous & chloroform extract of Phyllostachys bambusoides leaves. Int. J. Pharm. Prof. Res., 2: 355-358.
  25. Mehan, S., A. Verma, K.L. Bedi, V. Sehgal, A. Gupta, H. Meena and D. Sharma, 2011. Effect of mitogen activated protein kinase inhibitor in animal model of Alzheimer's disease. Int. J. Pharm. Prof. Res., 1: 212-223.
  26. Gupta, A., V. Sehgal and S. Mehan, 2011. Hyperlipidemia: An updated review. Int. J. Biopharm. Toxicol. Res., 1: 81-89.
  27. Verma, L., M. Sakir, N. Singh, R.M. Gilhotra and S. Mehan, 2010. Development of phase change solutions for ophthalmic drug delivery based on ion activated and pH induced polymers. Int. J. Pharm. Prof. Res., 1: 137-144.
    Direct Link  |  
  28. Nain, V.S., S. Nain, S. Mehan, J. Panu, R.R.D. Budhiraja, 2010. Apocynin supplementation: Comparison of thermal perception and oxidative stress in diabetic induced neuropathy. Int. J. Pharm. Prof. Res., 1: 114-121.
    Direct Link  |  
  29. Mehan, S., V.S. Nain, H. Meena, D. Sharma, R. Sankhla and M. Singh, 2010. Comparative effect of phosphodiesterase inhibitors on intracerebroventricular colchicine model of memory impairments in rats. Int. J. Pharm. Prof. Res., 1: 122-136.
    Direct Link  |  
  30. Mehan, S., D. Mishra, R. Sankhla and M. Singh, 2010. p38 MAPK kinase at the crossroads of Alzheimer`s disease. Int. J. Pharm. Prof. Res., 1: 52-60.
  31. Deshmukh, R., V. Sharma, S. Mehan, N. Sharma and K.L. Bedi, 2009. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine: A PDE1 inhibitor. Eur. J. Pharmacol., 620: 49-56.
    PubMed  |  Direct Link  |